XML 45 R35.htm IDEA: XBRL DOCUMENT
v3.21.2

Segment Information (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2021
Segment Reporting [Abstract] |
Reportable Segment Information |
| Three Months Ended |  | Nine Months Ended
| September 30, |  | September 30,
(DOLLARS IN MILLIONS) | 2021 |  | 2020 |  | 2021 |  | 2020
Net sales: |  |  |  |  |  |  |
Nourish | $ | 1,662 |  |  | $ | 712 |  |  | $ | 4,638 |  |  | $ | 2,174 |
Health & Biosciences | 618 |  |  | 31 |  |  | 1,683 |  |  | 99 |
Scent | 580 |  |  | 525 |  |  | 1,699 |  |  | 1,541 |
Pharma Solutions | 211 |  |  | — |  |  | 605 |  |  | — |
Consolidated | $ | 3,071 |  |  | $ | 1,268 |  |  | $ | 8,625 |  |  | $ | 3,814 |
Segment Adjusted Operating EBITDA |  |  |  |  |  |  |
Nourish | $ | 327 |  |  | $ | 148 |  |  | $ | 921 |  |  | $ | 466 |
Health & Biosciences | 151 |  |  | 10 |  |  | 469 |  |  | 29 |
Scent | 130 |  |  | 118 |  |  | 375 |  |  | 323 |
Pharma Solutions | 40 |  |  | — |  |  | 131 |  |  | — |
Total | 648 |  |  | 276 |  |  | 1,896 |  |  | 818 |
Depreciation & Amortization | (297) |  |  | (83) |  |  | (861) |  |  | (244) |
Interest Expense | (74) |  |  | (35) |  |  | (216) |  |  | (99) |
Other income (expense), net | 26 |  |  | (10) |  |  | 44 |  |  | (5) |
Frutarom Integration Related Costs (a) | (1) |  |  | (2) |  |  | (3) |  |  | (9) |
Restructuring and Other Charges | (6) |  |  | (1) |  |  | (34) |  |  | (8) |
Gains (Losses) on Sale of Assets | 1 |  |  | (1) |  |  | 1 |  |  | (2) |
Shareholder Activism Related Costs (b) | — |  |  | — |  |  | (7) |  |  | — |
Business Divestiture Costs (c) | (16) |  |  | — |  |  | (21) |  |  | — |
Employee Separation Costs (d) | (22) |  |  | — |  |  | (28) |  |  | — |
Frutarom Acquisition Related Costs (e) | — |  |  | (1) |  |  | — |  |  | (1) |
Compliance Review & Legal Defense Costs (f) | — |  |  | (1) |  |  | — |  |  | (2) |
N&B Inventory Step-Up Costs | 14 |  |  | — |  |  | (363) |  |  | — |
N&B Transaction Related Costs (g) | — |  |  | (8) |  |  | (91) |  |  | (24) |
N&B Integration Related Costs (h) | (23) |  |  | (29) |  |  | (77) |  |  | (62) |
Income Before Taxes | $ | 250 |  |  | $ | 105 |  |  | $ | 240 |  |  | $ | 362 |
_______________________
(a) | Represents costs related to the integration of the Frutarom acquisition. For 2021, costs primarily related to performance stock awards. For 2020, costs primarily related to advisory services, retention bonuses and performance stock awards.
(b) | Represents shareholder activist related costs, primarily professional fees.
(c) | Represents costs related to the Company's planned sales of businesses, primarily legal and professional fees.
(d) | Represents costs related to severance, including accelerated stock compensation expense, for certain employees and executives who have been separated or will separate from the Company.
(e) | Represents transaction-related costs and expenses related to the acquisition of Frutarom. For 2020, amount primarily includes earn-out payments, net of adjustments, amortization for inventory "step-up" costs and transaction costs principally related to the 2019 Acquisition Activity.
(f) | Costs related to reviewing the nature of inappropriate payments and review of compliance in certain other countries. In addition, includes legal costs for related shareholder lawsuits.
(g) | Represents transaction costs and expenses related to the transaction with N&B, primarily includes legal and professional fees.
(h) | Represents costs primarily related to advisory services for the integration of the transaction with N&B, primarily consulting fees.
Net Sales by Destination of Product Delivery | Net sales, which are attributed to individual regions based upon the destination of product delivery, were as follows:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
(DOLLARS IN MILLIONS) | 2021 |  | 2020 |  | 2021 |  | 2020
Europe, Africa and Middle East | $ | 1,084 |  |  | $ | 481 |  |  | $ | 3,041 |  |  | $ | 1,487 |
Greater Asia | 696 |  |  | 283 |  |  | 1,990 |  |  | 868 |
North America | 925 |  |  | 321 |  |  | 2,608 |  |  | 925 |
Latin America | 366 |  |  | 183 |  |  | 986 |  |  | 534 |
Consolidated | $ | 3,071 |  |  | $ | 1,268 |  |  | $ | 8,625 |  |  | $ | 3,814 |
| Three Months Ended September 30, |  | Nine Months Ended September 30,
(DOLLARS IN MILLIONS) | 2021 |  | 2020 |  | 2021 |  | 2020
Net sales related to the U.S. | $ | 860 |  |  | $ | 286 |  |  | $ | 2,390 |  |  | $ | 825 |
Net sales attributed to all foreign countries | 2,211 |  |  | 982 |  |  | 6,235 |  |  | 2,989 |

X
- Definition Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227 + Details
Name: | us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration